EUR 6.12
(-1.3%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 3.27 Million | 12.4 Million | 25.33 Million | 37.31 Million | 24.74 Million | 26.99 Million |
Net Income | -13.8 Million | 21.36 Million | 20.75 Million | 15.1 Million | 12.87 Million | 17.01 Million |
Depreciation & Amortization | 23.6 Million | 16.83 Million | 16.17 Million | 14.5 Million | 12.94 Million | 11.14 Million |
Deferred income taxes | -8.28 Million | 462 Thousand | -206 Thousand | 326 Thousand | 644 Thousand | 624 Thousand |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 8.17 Million | -27.29 Million | -14.84 Million | 7.29 Million | -2.04 Million | -1.66 Million |
Other non-cash items | 24.98 Million | 1.49 Million | 3.24 Million | 407 Thousand | 969 Thousand | 503 Thousand |
Investing Cash Flow | -13.44 Million | -44.19 Million | -15.29 Million | -23.3 Million | -34.35 Million | -25.67 Million |
Investments in PPE | -13.5 Million | -29.97 Million | -15.72 Million | -14.99 Million | -34.48 Million | -18.02 Million |
Acquisitions | 65 Thousand | -14.49 Million | 433 Thousand | -8.49 Million | -14.36 Million | -7.7 Million |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | 438 Thousand | 281 Thousand | 433 Thousand | 183 Thousand | 14.5 Million | 61 Thousand |
Financing Cash Flow | 13.69 Million | 5.65 Million | -3.06 Million | -1.33 Million | 12.95 Million | -5.52 Million |
Debt repayment | -4.64 Million | -7.91 Million | -4.11 Million | -5.28 Million | -1.42 Million | -1.22 Million |
Dividends payments | -4.23 Million | -6.18 Million | -5.8 Million | -2.6 Million | -5.1 Million | -6.48 Million |
Common Stock Repurchased | - | -2.73 Million | -3.91 Million | -228 Thousand | - | -3.28 Million |
Common Stock Issuance | 17.66 Million | - | 83 Thousand | - | 20.82 Million | 5.47 Million |
Other Financing Activities | -4.38 Million | 22.48 Million | 10.67 Million | 6.78 Million | -1.34 Million | -1000.00 |
Accounts receivables | 13.75 Million | -7.87 Million | -13.83 Million | -83 Thousand | -1.14 Million | -6.38 Million |
Accounts payables | -4.23 Million | 584 Thousand | 7.75 Million | 503 Thousand | 3.19 Million | -2.88 Million |
Inventory | 6.29 Million | -13.2 Million | -17.09 Million | 911 Thousand | 88 Thousand | 2.17 Million |
Other working capital | -7.63 Million | -6.79 Million | 8.32 Million | 5.96 Million | -4.18 Million | -3.83 Million |
Cash at beginning of period | 28.7 Million | 54.83 Million | 47.86 Million | 35.17 Million | 31.83 Million | 36.02 Million |
Cash at end of period | 32.22 Million | 28.7 Million | 54.83 Million | 47.86 Million | 35.17 Million | 31.83 Million |
Capital Expenditure | -13.5 Million | -29.97 Million | -15.72 Million | -14.99 Million | -34.48 Million | -18.02 Million |
Effect of forex changes on cash | 1000.00 | - | - | - | - | - |
Net cash flow / Change in cash | 3.52 Million | -26.13 Million | 6.97 Million | 12.68 Million | 3.34 Million | -4.19 Million |
Free Cash Flow | -10.23 Million | -17.57 Million | 9.6 Million | 22.32 Million | -9.74 Million | 8.97 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 532 Thousand | -3.9 Million | -13.8 Million | 3.71 Million | -15.85 Million | 515 Thousand |
Depreciation & Amortization | 4.55 Million | 4.37 Million | 23.6 Million | 5.29 Million | 8.62 Million | 4.84 Million |
Deferred income taxes | 76 Thousand | -446 Thousand | -8.28 Million | -7.41 Million | -1.17 Million | 278 Thousand |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -593 Thousand | -1.06 Million | 8.17 Million | 5.52 Million | 8.07 Million | -3.57 Million |
Other non-cash items | 11.87 Million | 9.93 Million | 24.98 Million | -1.49 Million | 118 Thousand | 469 Thousand |
Investing Cash Flow | -3.75 Million | -2.21 Million | -13.44 Million | -2.43 Million | -2.45 Million | -4.17 Million |
Investments in PPE | -3.06 Million | -2.21 Million | -13.5 Million | -2.08 Million | -2.62 Million | -4.42 Million |
Acquisitions | 472 Thousand | - | 65 Thousand | -352 Thousand | 168 Thousand | -240 Thousand |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | -1.16 Million | -1.76 Million | 438 Thousand | -1.00 | 168 Thousand | 489 Thousand |
Financing Cash Flow | -3.08 Million | -2.86 Million | 13.69 Million | -3.65 Million | -148 Thousand | 18.24 Million |
Debt repayment | -1.95 Million | -1.63 Million | -4.64 Million | -1.98 Million | -46 Thousand | -743 Thousand |
Dividends payments | - | - | -4.23 Million | - | - | -4.23 Million |
Common Stock Repurchased | - | - | - | - | - | 4.23 Million |
Common Stock Issuance | - | - | 17.66 Million | 81 Thousand | - | 17.58 Million |
Other Financing Activities | -1.13 Million | -436 Thousand | -4.38 Million | -1.75 Million | -102 Thousand | 1.4 Million |
Accounts receivables | -2.61 Million | -327 Thousand | 13.75 Million | 3.87 Million | 6.28 Million | 5.25 Million |
Accounts payables | -228 Thousand | -1.07 Million | -4.23 Million | 648 Thousand | -3.44 Million | -1.7 Million |
Inventory | 398 Thousand | -154 Thousand | 6.29 Million | 5.05 Million | 3.3 Million | 2.76 Million |
Other working capital | 1.85 Million | 492 Thousand | -7.63 Million | -4.04 Million | 1.92 Million | -9.88 Million |
Cash at beginning of period | 25.72 Million | 32.22 Million | 28.7 Million | 33.71 Million | 35.35 Million | 19.02 Million |
Cash at end of period | 23.77 Million | 25.72 Million | 32.22 Million | 32.22 Million | 33.71 Million | 35.35 Million |
Capital Expenditure | -3.06 Million | -2.21 Million | -13.5 Million | -2.08 Million | -2.62 Million | -4.42 Million |
Effect of forex changes on cash | - | - | 1000.00 | 1000.00 | - | - |
Net cash flow / Change in cash | -1.95 Million | -6.49 Million | 3.52 Million | -1.49 Million | -1.64 Million | 16.33 Million |
Free Cash Flow | 1.82 Million | -3.63 Million | -10.23 Million | 2.51 Million | -1.66 Million | -2.16 Million |
NEERAJ
GAN
APCOTEXIND
0316
0IUV
6128